Login to Your Account



VaxGen's AIDS Vaccine Comes Up Short; Blacks, Asians Show Benefit

By Aaron Lorenzo


Tuesday, February 25, 2003
VaxGen Inc. did not receive the results it and so many others hoped for after releasing Phase III trial data for its experimental AIDS vaccine, resulting in an investment backlash against the company's stock. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription